Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2 | N/A | 1,072 | 7 | 15 |
| Marketable Securities | N/A | N/A | 1,019 | N/A | N/A |
| Receivables | N/A | N/A | N/A | 25 | 25 |
| Other current assets | 0 | 0 | 228 | 4 | 4 |
| TOTAL | $2 | $N/A | $2,337 | $35 | $44 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 22 | N/A | N/A |
| Other Non-Current Assets | 0 | 0 | 6 | 0 | 0 |
| TOTAL | $N/A | $N/A | $28 | $N/A | $N/A |
| Total Assets | $2 | $N/A | $2,365 | $35 | $44 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,687 | N/A | N/A | 1,612 | 1,612 |
| Accounts payable and accrued liabilities | 91 | 0 | 15 | 171 | 174 |
| Accrued Expenses | 287 | N/A | 83 | 217 | 191 |
| TOTAL | $2,493 | $N/A | $98 | $2,285 | $2,214 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,493 | $N/A | $98 | $2,285 | $2,214 |
| Shareholders' Equity | |||||
| Common Shares | 1,102 | N/A | 3 | 1 | 1 |
| Retained earnings | -15,395 | N/A | -2,003 | -15,153 | -15,074 |
| Other shareholders' equity | -2,545 | 0 | 0 | -1,426 | -1,426 |
| TOTAL | $-2,491 | $N/A | $2,267 | $-2,250 | $-2,170 |
| Total Liabilities And Equity | $2 | $0 | $2,365 | $35 | $44 |